XENETIC BIOSCIENCES, INC. Shares Outstanding (Cover Page)
XENETIC BIOSCIENCES, INC. (XBIO) had Shares Outstanding (Cover Page) of 2.34 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 2.34M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 2.29M shares.
- 2026-04-17: Entity Common Stock, Shares Outstanding 2.29M shares.
- 2026-03-06: Entity Common Stock, Shares Outstanding 2.29M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 2.34M shares 10-Q · filed 2026-08-06 |
| 2026-05-08 | 2.29M shares 10-Q · filed 2026-05-12 |
| 2026-04-17 | 2.29M shares 10-K/A · filed 2026-04-24 |
| 2026-03-06 | 2.29M shares 10-K · filed 2026-03-12 |
| 2025-11-07 | 2.29M shares 10-Q · filed 2025-11-12 |
| 2025-08-07 | 1.54M shares 10-Q · filed 2025-08-12 |
| 2025-05-02 | 1.54M shares 10-Q · filed 2025-05-13 |
| 2025-04-18 | 1.54M shares 10-K/A · filed 2025-05-13 |
| 2025-03-07 | 1.54M shares 10-K · filed 2025-03-18 |
| 2024-11-08 | 1.54M shares 10-Q · filed 2024-11-12 |
| 2024-08-09 | 1.54M shares 10-Q · filed 2024-08-13 |
| 2024-05-03 | 1.54M shares 10-Q · filed 2024-05-09 |
| 2024-03-15 | 1.54M shares 10-K · filed 2024-03-21 |
| 2023-11-03 | 1.54M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 1.53M shares 10-Q · filed 2023-08-10 |
| 2023-05-05 | 15.17M shares 10-Q · filed 2023-05-11 |
| 2023-03-10 | 15.17M shares 10-K · filed 2023-03-22 |
| 2022-11-04 | 15.17M shares 10-Q · filed 2022-11-09 |
| 2022-08-05 | 14.32M shares 10-Q · filed 2022-08-11 |
| 2022-05-06 | 14.32M shares 10-Q · filed 2022-05-12 |
| 2022-03-18 | 13.44M shares 10-K · filed 2022-03-22 |
| 2021-11-05 | 13.39M shares 10-Q · filed 2021-11-12 |
| 2021-08-06 | 9.70M shares 10-Q · filed 2021-08-12 |
| 2021-05-07 | 8.75M shares 10-Q · filed 2021-05-11 |
| 2021-03-11 | 8.75M shares 10-K · filed 2021-03-16 |
| 2020-11-09 | 6.30M shares 10-Q · filed 2020-11-12 |
| 2020-08-07 | 6.30M shares 10-Q · filed 2020-08-12 |
| 2020-05-08 | 6.28M shares 10-Q · filed 2020-05-14 |
| 2020-03-06 | 6.28M shares 10-K · filed 2020-03-26 |
| 2019-11-08 | 5.76M shares 10-Q · filed 2019-11-14 |
| 2019-08-09 | 3.74M shares 10-Q · filed 2019-08-14 |
| 2019-05-06 | 10.44M shares 10-Q · filed 2019-05-13 |
| 2019-03-15 | 10.44M shares 10-K · filed 2019-03-29 |
| 2018-11-05 | 9.40M shares 10-Q · filed 2018-11-09 |
| 2018-08-06 | 9.40M shares 10-Q · filed 2018-08-10 |
| 2018-05-11 | 8.72M shares 10-Q · filed 2018-05-15 |
| 2018-03-30 | 8.65M shares 10-K · filed 2018-03-30 |
| 2017-11-13 | 8.72M shares 10-Q · filed 2017-11-14 |
| 2017-08-11 | 8.72M shares 10-Q · filed 2017-08-14 |
| 2017-05-11 | 8.72M shares 10-Q · filed 2017-05-15 |
| 2017-03-30 | 8.65M shares 10-K · filed 2017-03-31 |
| 2016-11-14 | 8.29M shares 10-Q · filed 2016-11-14 |
| 2016-08-15 | 9.02M shares 10-Q · filed 2016-08-15 |
| 2016-05-16 | 308.41M shares 10-Q · filed 2016-05-16 |
| 2016-03-30 | 151.98M shares 10-K · filed 2016-03-30 |
| 2015-11-16 | 150.51M shares 10-Q · filed 2015-11-16 |
| 2015-08-14 | 150.51M shares 10-Q · filed 2015-08-19 |
| 2015-05-15 | 149.99M shares 10-Q · filed 2015-05-20 |
| 2015-04-10 | 149.99M shares 10-K · filed 2015-04-15 |
| 2014-11-14 | 146.74M shares 10-Q · filed 2014-11-14 |
| 2014-08-14 | 146.74M shares 10-Q · filed 2014-08-14 |
| 2014-05-15 | 146.74M shares 10-Q · filed 2014-05-20 |
| 2014-04-15 | 146.74M shares 10-K · filed 2015-07-20 |
| 2014-01-03 | 135.00M shares 10-Q · filed 2014-01-10 |
| 2013-11-27 | 135.00M shares 10-K · filed 2013-11-27 |
| 2013-07-12 | 135.00M shares 10-Q · filed 2013-07-17 |
| 2013-04-18 | 135.00M shares 10-Q · filed 2013-04-22 |
| 2013-01-16 | 13.50M shares 10-Q · filed 2013-01-22 |
| 2012-12-12 | 13.50M shares 10-K · filed 2012-12-14 |
| 2012-07-10 | 13.50M shares 10-Q · filed 2012-07-16 |
| 2012-04-23 | 13.50M shares 10-Q · filed 2012-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |